Zura Bio Ltd (ZURA)

Jul 27, 2026

Zura Bio Ltd (ZURA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jul 27, 2026

Jul 27, 2026

Zura Bio Ltd (ZURA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jul 27, 2026

Jul 27, 2026

Zura Bio Ltd (ZURA) Cash Flow - TradingKey

Jul 27, 2026

Jul 27, 2026

Zura Bio Ltd (ZURA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jul 27, 2026

Jul 27, 2026

ZURA|Zura Bio Ltd|Price:5.230|Chg%:-0.060 - TradingKey

Jul 27, 2026

Jul 27, 2026

Zura Bio Ltd (ZURA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jul 27, 2026

Jul 27, 2026

Zura Bio Ltd (ZURA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jul 27, 2026

Jul 26, 2026

TradingKey - TradingKey

Jul 26, 2026

Jul 18, 2026

Marlyn Teresa Mathew Net Worth (2026) - GuruFocus

Jul 18, 2026

Jul 14, 2026

William Blair Starts Zura Bio (ZURA) at Outperform - Yahoo Finance

Jul 14, 2026

Jul 08, 2026

ZURA Initiated Coverage by William Blair -- Rating Set to Outper - GuruFocus

Jul 08, 2026

Jul 08, 2026

What's Going on With Zura Bio Stock Wednesday?Zura Bio (NASDAQ:ZURA) - Benzinga

Jul 08, 2026

Jul 08, 2026

Zura Bio navigates growth path amid biotech volatility - Ad-hoc-news.de

Jul 08, 2026

Jul 08, 2026

William Blair initiates Zura Bio stock with outperform rating By Investing.com - Investing.com Nigeria

Jul 08, 2026

Jul 08, 2026

William Blair initiates Zura Bio stock with outperform rating - Investing.com

Jul 08, 2026

Jul 08, 2026

William Blair Initiates Zura Bio(ZURA.US) With Buy Rating - Moomoo

Jul 08, 2026

Jul 07, 2026

Zura Bio stock. Company profile and listing context. - Ad-hoc-news.de

Jul 07, 2026

Jul 01, 2026

Zura Bio’s Tibulizumab: First Dual BAFF & IL-17 Bispecific Antibody for Complex Autoimmune Diseases, Advancing in Phase 2 Trials – Minichart - Minichart

Jul 01, 2026

Jul 01, 2026

Jessica Chen - White & Case LLP

Jul 01, 2026

Jul 01, 2026

Zura Bio updates corporate presentation; tibulizumab Phase 2 toplines, $225.6M cash (Mar 31, 2026) - TradingView

Jul 01, 2026

Jul 01, 2026

Zura Bio (NASDAQ: ZURA) furnishes updated corporate presentation for investors - Stock Titan

Jul 01, 2026

Jun 30, 2026

Guggenheim Maintains Zura Bio(ZURA.US) With Buy Rating, Maintains Target Price $15 - Moomoo

Jun 30, 2026

Jun 30, 2026

We're Hopeful That Zura Bio (NASDAQ:ZURA) Will Use Its Cash Wisely - simplywall.st

Jun 30, 2026

Jun 29, 2026

Zura Bio completes enrollment in tibulizumab trials By Investing.com - Investing.com South Africa

Jun 29, 2026

Jun 29, 2026

ZURA Financial Update: Cash Position and Operational Outlook - GuruFocus

Jun 29, 2026

Jun 29, 2026

Zura Bio completes Phase 2 trial enrollment for tibulizumab in hidradenitis suppurativa - Traders Union

Jun 29, 2026

Jun 29, 2026

Zura Bio clears enrollment targets in two Phase 2 studies, adds a third - Stock Titan

Jun 29, 2026

Jun 22, 2026

Zura Bio (ZURA) VP details share, RSU and option holdings - Stock Titan

Jun 22, 2026

Jun 22, 2026

Zura Bio | 4: Statement of changes in beneficial ownership of securities-Director Jarrett Jennifer - Moomoo

Jun 22, 2026

Jun 22, 2026

Zura Bio (NASDAQ: ZURA) director receives grant of 51,000 share options - Stock Titan

Jun 22, 2026

Jun 22, 2026

Zura Bio (ZURA) director awarded 51,000 share options at $3.62 - Stock Titan

Jun 22, 2026

Jun 22, 2026

Zura Bio (ZURA) director receives grant of 51,000 stock options - Stock Titan

Jun 22, 2026

Jun 22, 2026

Zura Bio (ZURA) director Amit Munshi granted 51,000 share options at $3.62 - Stock Titan

Jun 22, 2026

Jun 22, 2026

Zura Bio (ZURA) director Daniel Becker receives 51,000 share options at $3.62 - Stock Titan

Jun 22, 2026

Jun 22, 2026

Director at Zura Bio (NASDAQ: ZURA) granted 51,000 stock options - Stock Titan

Jun 22, 2026

Jun 22, 2026

Zura Bio (ZURA) director receives 51,000 share options at $3.62 strike price - Stock Titan

Jun 22, 2026

Jun 20, 2026

Zura Bio StockSaturday look at the business model and pipeline - AD HOC NEWS

Jun 20, 2026

Jun 18, 2026

Zura Bio (NASDAQ: ZURA) investors approve board slate, auditor and 2023 equity plan changes - Stock Titan

Jun 18, 2026

Jun 18, 2026

Zura Bio Ltd (ZURA) Institutional Confidence - TradingKey

Jun 18, 2026

Jun 17, 2026

Zura Bio Ltd (ZURA) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 17, 2026

Jun 17, 2026

Zura Bio Ltd (ZURA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 17, 2026

Jun 17, 2026

Zura Bio Ltd (ZURA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 17, 2026

Jun 10, 2026

Zura Bio Ltd stock (KYG989201089): Pipeline update and capital raise reshape the story - AD HOC NEWS

Jun 10, 2026

Jun 03, 2026

Here's Why We're Not Too Worried About Zura Bio's (NASDAQ:ZURA) Cash Burn Situation - Yahoo Finance

Jun 03, 2026

May 30, 2026

ZURAZura Bio Ltd Stock Price and Quote - Finviz

May 30, 2026

May 22, 2026

Zura Bio (NASDAQ: ZURA) discloses resignation of director Someit Sidhu - Stock Titan

May 22, 2026

May 16, 2026

Zura Bio Ltd stock (KYG989201089): pipeline update keeps autoimmune story in focus - AD HOC NEWS

May 16, 2026

May 15, 2026

Venrock entities report 9.99% ownership in ZURA (ZURA) - Stock Titan

May 15, 2026

May 15, 2026

Great Point Partners, Dr. Jay & Nordahl report 4.44% in ZURA (ZURA) - Stock Titan

May 15, 2026

May 14, 2026

Zura Bio reports inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com

May 14, 2026

May 14, 2026

Zura Bio stock (KYG989201089): Appoints Muzammil Mustufa as Chief Business Officer - AD HOC NEWS

May 14, 2026

May 14, 2026

Zura Bio's new CBO gets options on 600,000 shares at $4.80 - Stock Titan

May 14, 2026

May 13, 2026

Zura Bio appoints Muzammil Mustufa as chief business officer By Investing.com - Investing.com Canada

May 13, 2026